Literature DB >> 23175139

Age at menarche and risk of ovarian cancer: a meta-analysis of epidemiological studies.

Ting-Ting Gong1, Qi-Jun Wu, Emily Vogtmann, Bei Lin, Yong-Lai Wang.   

Abstract

Epidemiological studies have reported inconsistent associations between menarcheal age and ovarian cancer risk. To our knowledge, a meta-analysis for the association between menarcheal age and ovarian cancer has not been reported. Relevant published studies of menarcheal age and ovarian cancer were identified using MEDLINE, EMBASE and Web of Science through the end of April 2012. Two authors (T-T.G. and Q-J.W.) independently assessed eligibility and extracted data. We pooled the relative risks (RRs) from individual studies using a random-effects model and performed heterogeneity and publication bias analyses. A total of 27 observational studies consisting of 22 case-control and five cohort studies were included in our analysis. In a pooled analysis of all studies, a statistically significant inverse association was observed between menarcheal age (for the oldest compared to the youngest category) and ovarian cancer risk (RR = 0.85; 95% confidence interval [CI] = 0.75-0.97). The pooled RRs of ovarian cancer for the oldest versus the youngest categories of menarcheal age in prospective and case-control studies were 0.89 (95% CI = 0.76-1.03) and 0.84 (95% CI = 0.70-0.99), respectively. Inverse associations between menarcheal age and ovarian cancer risk were observed in most subgroups; however, the significant association was restricted to invasive and borderline serous ovarian cancer. In conclusion, findings from this meta-analysis support that menarcheal age was inversely associated with the risk of ovarian cancer. More large studies are warranted to stratify these results by different cancer grading and histotype of ovarian cancer.
Copyright © 2012 UICC.

Entities:  

Mesh:

Year:  2012        PMID: 23175139      PMCID: PMC3806278          DOI: 10.1002/ijc.27952

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  48 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

3.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

4.  [Proceedings: Correlation among the age at menarche, the number of parity and the age at menopause].

Authors:  Y Okada; S Yagi; N Katsu; Y Mabuchi; S Yokota
Journal:  Nihon Naibunpi Gakkai Zasshi       Date:  1974-02-20

5.  Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use.

Authors:  M L Wu; A S Whittemore; R S Paffenbarger; D L Sarles; J B Kampert; S Grosser; D L Jung; S Ballon; M Hendrickson; J Mohle-Boetani
Journal:  Am J Epidemiol       Date:  1988-12       Impact factor: 4.897

6.  Operating characteristics of a rank correlation test for publication bias.

Authors:  C B Begg; M Mazumdar
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

7.  Ovarian cancer risk factors in African-American and white women.

Authors:  Patricia G Moorman; Rachel T Palmieri; Lucy Akushevich; Andrew Berchuck; Joellen M Schildkraut
Journal:  Am J Epidemiol       Date:  2009-07-15       Impact factor: 4.897

8.  Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis?

Authors:  G C Rodriguez; D K Walmer; M Cline; H Krigman; B A Lessey; R S Whitaker; R Dodge; C L Hughes
Journal:  J Soc Gynecol Investig       Date:  1998 Sep-Oct

9.  The epidemiology of ovarian cancer in Greece: a case-control study.

Authors:  A Tzonou; N E Day; D Trichopoulos; A Walker; M Saliaraki; M Papapostolou; A Polychronopoulou
Journal:  Eur J Cancer Clin Oncol       Date:  1984-08

10.  The human ovarian surface epithelium is an androgen responsive tissue.

Authors:  R J Edmondson; J M Monaghan; B R Davies
Journal:  Br J Cancer       Date:  2002-03-18       Impact factor: 7.640

View more
  48 in total

1.  Ovarian Cancer in Women of African Ancestry (OCWAA) consortium: a resource of harmonized data from eight epidemiologic studies of African American and white women.

Authors:  Joellen M Schildkraut; Lauren C Peres; Traci N Bethea; Fabian Camacho; Deanna Chyn; Emily K Cloyd; Elisa V Bandera; Alicia Beeghly-Fadiel; Loren Lipworth; Charlotte E Joslin; Faith G Davis; Patricia G Moorman; Evan Myers; Heather M Ochs-Balcom; Veronica Wendy Setiawan; Malcolm C Pike; Anna H Wu; Lynn Rosenberg
Journal:  Cancer Causes Control       Date:  2019-06-24       Impact factor: 2.506

2.  Breastfeeding and ovarian cancer risk: a meta-analysis of epidemiologic studies.

Authors:  Nan-Nan Luan; Qi-Jun Wu; Ting-Ting Gong; Emily Vogtmann; Yong-Lai Wang; Bei Lin
Journal:  Am J Clin Nutr       Date:  2013-08-21       Impact factor: 7.045

3.  Menstrual cycle characteristics and steroid hormone, prolactin, and growth factor levels in premenopausal women.

Authors:  Leslie V Farland; Fan Mu; A Heather Eliassen; Susan E Hankinson; Shelley S Tworoger; Robert L Barbieri; Mitch Dowsett; Michael N Pollak; Stacey A Missmer
Journal:  Cancer Causes Control       Date:  2017-10-31       Impact factor: 2.506

Review 4.  Role of the IL-33/ST2 receptor axis in ovarian cancer progression.

Authors:  Ning Liu; Jintong Chen; Yinghua Zhao; Mingyue Zhang; Li Piao; Siqing Wang; Ying Yue
Journal:  Oncol Lett       Date:  2021-04-29       Impact factor: 2.967

5.  Comparison of Clinical, Maternal, and Self Pubertal Assessments: Implications for Health Studies.

Authors:  Mary Beth Terry; Mandy Goldberg; Sarah Schechter; Lauren C Houghton; Melissa L White; Karen O'Toole; Wendy K Chung; Mary B Daly; Theresa H M Keegan; Irene L Andrulis; Angela R Bradbury; Lisa Schwartz; Julia A Knight; Esther M John; Saundra S Buys
Journal:  Pediatrics       Date:  2016-06-08       Impact factor: 7.124

6.  Consumption of caffeinated and artificially sweetened soft drinks is associated with risk of early menarche.

Authors:  Noel T Mueller; David R Jacobs; Richard F MacLehose; Ellen W Demerath; Scott P Kelly; Jill G Dreyfus; Mark A Pereira
Journal:  Am J Clin Nutr       Date:  2015-07-15       Impact factor: 7.045

7.  Faster ticking rate of the epigenetic clock is associated with faster pubertal development in girls.

Authors:  Alexandra M Binder; Camila Corvalan; Verónica Mericq; Ana Pereira; José Luis Santos; Steve Horvath; John Shepherd; Karin B Michels
Journal:  Epigenetics       Date:  2018-02-15       Impact factor: 4.528

8.  Association between antidepressant medication use and epithelial ovarian cancer risk: a systematic review and meta-analysis of observational studies.

Authors:  Yun-Long Huo; Jia-Ming Qiao; Song Gao
Journal:  Br J Clin Pharmacol       Date:  2018-02-05       Impact factor: 4.335

9.  Long non-coding RNAs in ovarian cancer: expression profile and functional spectrum.

Authors:  Selin Oncul; Paola Amero; Cristian Rodriguez-Aguayo; George A Calin; Anil K Sood; Gabriel Lopez-Berestein
Journal:  RNA Biol       Date:  2019-12-17       Impact factor: 4.652

10.  Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.

Authors:  Merlise A Clyde; Rachel Palmieri Weber; Edwin S Iversen; Elizabeth M Poole; Jennifer A Doherty; Marc T Goodman; Roberta B Ness; Harvey A Risch; Mary Anne Rossing; Kathryn L Terry; Nicolas Wentzensen; Alice S Whittemore; Hoda Anton-Culver; Elisa V Bandera; Andrew Berchuck; Michael E Carney; Daniel W Cramer; Julie M Cunningham; Kara L Cushing-Haugen; Robert P Edwards; Brooke L Fridley; Ellen L Goode; Galina Lurie; Valerie McGuire; Francesmary Modugno; Kirsten B Moysich; Sara H Olson; Celeste Leigh Pearce; Malcolm C Pike; Joseph H Rothstein; Thomas A Sellers; Weiva Sieh; Daniel Stram; Pamela J Thompson; Robert A Vierkant; Kristine G Wicklund; Anna H Wu; Argyrios Ziogas; Shelley S Tworoger; Joellen M Schildkraut
Journal:  Am J Epidemiol       Date:  2016-10-03       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.